Assura plc is a specialist real estate investment trust (REIT) focused on the acquisition, development and management of primary healthcare properties in the United Kingdom. The company’s portfolio comprises purpose-built medical centres that are leased on long-term agreements to NHS bodies, GP practices and private healthcare providers. Assura’s business model emphasizes the creation of modern, energy-efficient facilities configured to meet evolving clinical and patient needs across underserved and growth markets.
Through an integrated approach to asset management and development, Assura targets properties with strong local demand drivers, often securing sites through competitive tenders or preferred partnerships with healthcare commissioners. Its lease structures typically include inflation-linked rent reviews, providing income visibility and resilience. The company also pursues selective greenfield developments and forward-fund agreements to capture new catchments and expand its geographic reach.
Founded in 2006 and listed on the London Stock Exchange, Assura converted to REIT status in January 2013 in order to optimize its tax position and enhance shareholder returns. Headquartered in Altrincham, Cheshire, the company has delivered a track record of disciplined capital deployment and portfolio growth, with over 500 medical centres operated or in development across England, Scotland and Wales. The board is chaired by Norman Scarth and its executive leadership team is led by chief executive officer Chris Miller.
In the United States, Assura’s ordinary shares trade over-the-counter under the ticker ARSSF, providing international investors with access to its UK-focused healthcare real estate strategy.
AI Generated. May Contain Errors.
